20 min listen
Emerging Insights on Adverse Events During ART and Implications for Treatment: Nephrotoxicity and Long-Acting Injectables
Emerging Insights on Adverse Events During ART and Implications for Treatment: Nephrotoxicity and Long-Acting Injectables
ratings:
Length:
40 minutes
Released:
Nov 16, 2021
Format:
Podcast episode
Description
In this episode, Fidelia Bernice, PharmD, and Aadia I. Rana, MD, share insights on HIV ART safety and tolerability including recent data on nephrotoxicity and the use of NRTI-sparing regimens with discussion of the GEMINI-1 and -2 studies of DTG/3TC and the SWORD-1 and -2 studies of DTG/RPV, and safety with long-acting injectables with specific discussion of the ATLAS and FLAIR studies of LA CAB plus RPV and the CUSTOMIZE study.Presenters:Fidelia Bernice, PharmDClinical Pharmacy SpecialistInfectious DiseasesDepartment of PharmacyUniversity of Maryland Medical CenterBaltimore, MarylandAadia I. Rana, MDAssociate Professor of MedicineDivision of Infectious DiseasesUniversity of Alabama at Birmingham1917 ClinicBirmingham, AlabamaContent based on a CME program supported by independent educational grants fromJanssen Therapeutics, Division of Janssen Products, LP, and ViiV Healthcare.Link to full program:https://bit.ly/3ydMtcL
Released:
Nov 16, 2021
Format:
Podcast episode
Titles in the series (100)
Benefits of and Need for Integrated Addiction and Infectious Disease Care: Listen to an insightful discussion between infectious disease experts, Christian B. Ramers, MD, MPH, and Sandra Springer, MD, on current evidence supporting the need for integrated addiction and infectious disease care services. by CCO Infectious Disease Podcast